Product Information
LYRICA 225 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.6730 per EA under NDC 58151024377. Its NADAC has been published 51 times since Jul 9, 2025.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
225 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151024377
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446On Market Since
5/8/2025
Price Statistics
The NADAC for LYRICA 225 MG CAPSULE has been published 51 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6730 per EA |
|---|---|
| All-time high | $9.7043 (Jan 14, 2026) |
| All-time low | $9.6730 (Jun 17, 2026) |
| 52-week high | $9.7043 |
| 52-week low | $9.6730 |
| Median price | $9.6831 |
| Average price | $9.6837 |
| Largest weekly change | +0.3% (Dec 17, 2025) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LYRICA 225 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 225 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.6730 per EA (NDC 58151024377), effective Jun 24, 2026.
How has the price of LYRICA 225 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 225 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for LYRICA 225 MG CAPSULE?
Since Jul 9, 2025, the NADAC for LYRICA 225 MG CAPSULE has ranged from a low of $9.6730 (Jun 17, 2026) to a high of $9.7043 (Jan 14, 2026), with a median of $9.6831 per EA.
Are there cheaper alternatives to LYRICA 225 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0555 per EA — about 99% below LYRICA 225 MG CAPSULE.
Who manufactures LYRICA 225 MG CAPSULE?
LYRICA 225 MG CAPSULE (NDC 58151024377) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification